Colgate-Palmolive steady into next earnings, S&P 500 consumer stock stays richly valued

Colgate-Palmolive enters the next earnings round with a premium valuation and solid S&P 500 standing. Consensus points to continued organic sales growth and stable margins for the NYSE-listed consumer staples group.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 17:25.

Colgate-Palmolive Co (US1941621039) heads toward its next NYSE earnings update with a premium valuation for a consumer staples name. MarketBeat data show the S&P 500 constituent last reported earnings on April 26, 2026, and the next quarterly release is expected in late July 2026, based on its historical reporting pattern and consensus tracking.

What analysts expect now

According to the latest overview from MarketBeat, Wall Street forecasters see Colgate-Palmolive delivering full-year 2026 earnings per share of around 3.06 US dollars, implying mid-single-digit growth versus the trailing twelve months. The site also reports that the consensus rating sits in the Buy-to-Hold range, with most houses emphasizing the group’s resilience in oral and personal care.

On a trailing basis, data from MEXC indicate that Colgate-Palmolive currently trades at a price-to-earnings ratio of about 34 on earnings per share of roughly 2.61 US dollars, well above the broader S&P 500 consumer staples average. The platform also shows a market capitalization in the low-70-billion-dollar range, underlining the company’s position alongside peers such as Procter & Gamble and Unilever in the global branded household products space.

Valuation, sentiment and peer context

MEXC quotes the Colgate-Palmolive shares at 89.03 US dollars as of June 22, 2026, a marginal 0.04 percent slip versus the previous close of 89.48 US dollars, with the stock still near its recent 52-week upper band. The same dataset cites a trailing P/E ratio of 34.31, reflecting investors’ willingness to pay a clear premium for steady cash flows and consistent dividend growth in a defensive S&P 500 sector.

Alternative indicators paint a more cautious short-term picture: sentiment tracker Adanos reports that Colgate-Palmolive currently screens as a sell signal across Reddit, X and news flow, with an average bullish reading of just 33 percent over the last seven days. That divergence between solid fundamentals and muted retail sentiment underscores the contrast to some faster-growing peers, even as the stock’s volatility remains relatively contained compared with broader consumer names.

How Colgate-Palmolive earns its money

Colgate-Palmolive generates the bulk of its revenue from oral care, with the Colgate toothpaste franchise a leading brand in many markets worldwide, complemented by toothbrushes, mouthwash and related products. Beyond oral care, the company sells Palmolive-branded shower gels and soaps, home care cleaners and pet nutrition under the Hill’s brand, giving it a diversified but still consumer-staples-focused portfolio.

Where the shares trade today

The Colgate-Palmolive shares (US1941621039) trade on the NYSE at 89.03 US dollars as of 2026-06-22, 10:16 Eastern Time, according to MEXC price data.

Key data on the Colgate-Palmolive shares

• Company: Colgate-Palmolive Company
• ISIN: US1941621039
• WKN: 850667
• Ticker: CL
• Trading venue: NYSE
• Price (as of 2026-06-22, 10:16): 89.03 USD
• Market cap: around 72 billion USD (as of 2026-06-22)
• Sector / industry: Consumer Staples / Household & Personal Products
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities.